Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L LeBlanc

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Physiology|July 1, 1994
Systemic and regional hemodynamics after nitric oxide synthase inhibition: role of a neurogenic mechanismM Huang, M L Leblanc, R L Hester
Genetic Epidemiology|January 17, 2002
Sequence analysis using logic regressionC Kooperberg, I Ruczinski, M L LeBlanc, et al.
Arthritis and Rheumatism|January 1, 1980
Hypermobility in psoriatic spondylitisM L LeBlanc, W G Bensen, W M Goldberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Physiology|July 1, 1994
Systemic and regional hemodynamics after nitric oxide synthase inhibition: role of a neurogenic mechanismM Huang, M L Leblanc, R L Hester
Genetic Epidemiology|January 17, 2002
Sequence analysis using logic regressionC Kooperberg, I Ruczinski, M L LeBlanc, et al.
Arthritis and Rheumatism|January 1, 1980
Hypermobility in psoriatic spondylitisM L LeBlanc, W G Bensen, W M Goldberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Pageof 1